- Investigator
- Whitney W Woodmansee
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Pituitary Neoplasms , 14 publications
- Human Growth Hormone , 11 publications
- Adenoma , 9 publications
- Pituitary Gland , 8 publications
Research activity
Focus
Dr. Woodmansee has been involved in both basic science and clinical research and has numerous publications in the pituitary/thyroid field. Spending much of her career specializing in pituitary and thyroid disorders, she has also served as director of the Clinical Neuroendocrine Program at the Brigham and Women’s Hospital/ Harvard Medical School in Boston, MA and the medical director of the Neuroendocrine/Pituitary Program at the Mayo Clinic in Jacksonville, FL. Dr. Woodmansee has been a principal investigator in a number of clinical trials related to pituitary disorders and her current primary research interest is in the area of hypopituitarism. She specializes in treating patients with pituitary and thyroid disorders.
Active clinical trials
My publications
Filter publications
54 publications
2018
Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.
Endocrine
PubMed • Publisher's site2017
A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.
Pituitary
PubMed • Publisher's site2017
Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.
The Journal of clinical endocrinology and metabolism
PubMed • Publisher's site2017
Stem cell therapy and its potential role in pituitary disorders.
Current opinion in endocrinology, diabetes, and obesity
PubMed • Publisher's site2016
A Benchmark for Preservation of Normal Pituitary Function After Endoscopic Transsphenoidal Surgery for Pituitary Macroadenomas.
World neurosurgery
PubMed • Publisher's site